CD40 ligand exhibits a direct antiviral effect on Herpes Simplex Virus type-1 infection via a PI3K-dependent, autophagy-independent mechanism.

Autor: Vlahava VM; Laboratory of Clinical Virology, Medical School, University of Crete, Heraklion, Crete, Greece., Eliopoulos AG; Molecular and Cellular Biology Laboratory, Medical School, University of Crete, Heraklion, Crete, Greece; Institute of Molecular Biology & Biotechnology, FORTH, Heraklion, Crete, Greece., Sourvinos G; Laboratory of Clinical Virology, Medical School, University of Crete, Heraklion, Crete, Greece. Electronic address: sourvino@med.uoc.gr.
Jazyk: angličtina
Zdroj: Cellular signalling [Cell Signal] 2015 Jun; Vol. 27 (6), pp. 1253-63. Date of Electronic Publication: 2015 Mar 10.
DOI: 10.1016/j.cellsig.2015.03.002
Abstrakt: The interaction between CD40 and its ligand, CD40L/CD154, is crucial for the efficient initiation and regulation of immune responses against viruses. Herpes Simplex Virus type-1 (HSV-1) is a neurotropic virus capable of manipulating host responses and exploiting host proteins to establish productive infection. Herein we have examined the impact of CD40L-mediated CD40 activation on HSV-1 replication in U2OS cells stably expressing the CD40 receptor. Treatment of these cells with CD40L significantly reduced the HSV-1 progeny virus compared to non-treated cells. The activation of CD40 signaling did not affect the binding of HSV-1 virions on the cell surface but rather delayed the translocation of VP16 to the nucleus, affecting all stages of viral life cycle. Using pharmacological inhibitors and RNAi we show that inhibition of PI3 kinase but not autophagy reverses the effects of CD40L on HSV-1 replication. Collectively, these data demonstrate that CD40 activation exerts a direct inhibitory effect on HSV-1, initiating from the very early stages of the infection by exploiting PI3 kinase-dependent but autophagy-independent mechanisms.
(Copyright © 2015 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: